MAML3 antisense RNA 1 (MAML3-AS1)

MAML3 antisense RNA 1 (MAML3-AS1) is an antisense long non-coding RNA gene located in the human genome near the MAML3 gene, which encodes Mastermind-like transcriptional coactivator 3[1]. There is little or no characterization in the scientific literature regarding its specific biological functions, disease associations, or role as a therapeutic target, and it is not recognized as a protein-coding gene or a direct drug target[1]. The related MAML3 protein, not MAML3-AS1, is known as a transcriptional coactivator involved in the Notch signaling pathway, but antisense RNAs such as MAML3-AS1 typically regulate gene expression post-transcriptionally through various RNA-mediated mechanisms, which remain uncharacterized for this particular lncRNA[1]. Key context: - MAML3-AS1 is *not* a canonical therapeutic target; there are no drugs or known mechanisms of action associated with it, and it is not represented in current disease biomarker or drug-interaction databases[1]. - MAML3-AS1 should not be confused with **MAML3**, the protein-coding gene often studied in the context of transcriptional regulation and cancer[2][3][5]. - Due to the current lack of information, MAML3-AS1 is best classified as an uncharacterized lncRNA rather than as a classical target molecule. If you intended to refer to “MAML3” (Mastermind-like transcriptional coactivator 3), please clarify, as there is significantly more information and clinical relevance for that protein.

None known